• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

气道细菌群落的变化在囊性纤维化肺部恶化开始抗生素治疗后很快发生。

Changes in airway bacterial communities occur soon after initiation of antibiotic treatment of pulmonary exacerbations in cystic fibrosis.

机构信息

Department of Pediatrics, University of Michigan Medical School, 1150 West Medical Center Drive, Ann Arbor, MI 48109, United States.

Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH, United States.

出版信息

J Cyst Fibros. 2022 Sep;21(5):766-768. doi: 10.1016/j.jcf.2022.05.011. Epub 2022 Jun 4.

DOI:10.1016/j.jcf.2022.05.011
PMID:35667975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10440828/
Abstract

Chronic polymicrobial airway infections are a hallmark of cystic fibrosis (CF) lung disease. Antibiotic therapy is a primary treatment of CF pulmonary exacerbations (PEx); however, the impact of episodic antibiotic treatment on airway bacterial communities has not been well described. We analyzed sputum samples from adults with CF obtained immediately before and during antibiotic treatment of PEx. Sequencing of the V4 region of the bacterial 16S ribosomal RNA gene was used to assess changes in bacterial community structure during antibiotic treatment. The peak impact of antibiotic treatment was observed by day four or five of treatment. These findings advance our understanding of bacterial community dynamics during antibiotic treatment of PEx and complement recent and ongoing studies evaluating the optimal duration of antibiotic therapy for PEx.

摘要

慢性多微生物气道感染是囊性纤维化 (CF) 肺部疾病的一个标志。抗生素治疗是 CF 肺部感染加重 (PEx) 的主要治疗方法;然而,间歇性抗生素治疗对气道细菌群落的影响尚未得到很好的描述。我们分析了 CF 成人在 PEx 抗生素治疗前和治疗期间立即获得的痰样本。使用细菌 16S 核糖体 RNA 基因 V4 区的测序来评估抗生素治疗期间细菌群落结构的变化。在治疗的第四天或第五天观察到抗生素治疗的峰值影响。这些发现增进了我们对 PEx 抗生素治疗期间细菌群落动态的理解,并补充了最近和正在进行的评估 PEx 抗生素治疗最佳持续时间的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b0/10440828/fb9a554d0c89/nihms-1923370-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b0/10440828/6aa86c8557d6/nihms-1923370-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b0/10440828/fb9a554d0c89/nihms-1923370-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b0/10440828/6aa86c8557d6/nihms-1923370-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b0/10440828/fb9a554d0c89/nihms-1923370-f0002.jpg

相似文献

1
Changes in airway bacterial communities occur soon after initiation of antibiotic treatment of pulmonary exacerbations in cystic fibrosis.气道细菌群落的变化在囊性纤维化肺部恶化开始抗生素治疗后很快发生。
J Cyst Fibros. 2022 Sep;21(5):766-768. doi: 10.1016/j.jcf.2022.05.011. Epub 2022 Jun 4.
2
Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability.囊性纤维化气道微生物组在临床稳定期的测量。
Ann Am Thorac Soc. 2019 Dec;16(12):1534-1542. doi: 10.1513/AnnalsATS.201903-270OC.
3
Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.在囊性纤维化肺部恶化期间的炎症和气道微生物群。
PLoS One. 2013 Apr 30;8(4):e62917. doi: 10.1371/journal.pone.0062917. Print 2013.
4
The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.成人囊性纤维化气道微生物群随时间和感染类型保持稳定,并且对加重期的抗生素治疗具有高度弹性。
PLoS One. 2012;7(9):e45001. doi: 10.1371/journal.pone.0045001. Epub 2012 Sep 26.
5
Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.囊性纤维化肺部加重期期间铜绿假单胞菌痰密度的降低并不能预测临床反应。
BMC Infect Dis. 2015 Mar 22;15:145. doi: 10.1186/s12879-015-0856-5.
6
Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.微生物群落组织指定了不同的肺部恶化类型,并预测了囊性纤维化的治疗结果。
Nat Commun. 2024 Jun 7;15(1):4889. doi: 10.1038/s41467-024-49150-y.
7
The Elusive Role of Airway Infection in Cystic Fibrosis Exacerbation.气道感染在囊性纤维化加重中的作用难以捉摸。
J Pediatric Infect Dis Soc. 2022 Sep 7;11(Supplement_2):S40-S45. doi: 10.1093/jpids/piac062.
8
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].[中国专家共识声明:囊性纤维化的诊断与治疗(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971.
9
Decade-long bacterial community dynamics in cystic fibrosis airways.囊性纤维化气道中长达十年的细菌群落动态。
Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5809-14. doi: 10.1073/pnas.1120577109. Epub 2012 Mar 26.
10
Polymicrobial infections and antibiotic treatment patterns for cystic fibrosis pulmonary exacerbations.囊性纤维化肺部加重期的多微生物感染及抗生素治疗模式
J Cyst Fibros. 2023 Jul;22(4):630-635. doi: 10.1016/j.jcf.2023.02.001. Epub 2023 Feb 26.

引用本文的文献

1
Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.微生物群落组织指定了不同的肺部恶化类型,并预测了囊性纤维化的治疗结果。
Nat Commun. 2024 Jun 7;15(1):4889. doi: 10.1038/s41467-024-49150-y.
2
Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation.儿童干细胞移植患者中菌群失调性肺损伤的病理生物学特征。
Nat Med. 2024 Jul;30(7):1982-1993. doi: 10.1038/s41591-024-02999-4. Epub 2024 May 23.
3
Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.

本文引用的文献

1
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.一项囊性纤维化肺部感染加重治疗中抗菌疗程的随机临床试验。
Am J Respir Crit Care Med. 2021 Dec 1;204(11):1295-1305. doi: 10.1164/rccm.202102-0461OC.
2
Parallel Analysis of Cystic Fibrosis Sputum and Saliva Reveals Overlapping Communities and an Opportunity for Sample Decontamination.囊性纤维化痰液和唾液的平行分析揭示了重叠菌群以及样本净化的机会。
mSystems. 2020 Jul 7;5(4):e00296-20. doi: 10.1128/mSystems.00296-20.
3
Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability.
微生物群落组织可区分不同的肺部加重类型,并预测囊性纤维化的治疗结果。
Res Sq. 2024 Mar 21:rs.3.rs-4128740. doi: 10.21203/rs.3.rs-4128740/v1.
4
Pulmonary microbiome and transcriptome signatures reveal distinct pathobiologic states associated with mortality in two cohorts of pediatric stem cell transplant patients.肺部微生物组和转录组特征揭示了与两组儿科干细胞移植患者死亡率相关的不同病理生物学状态。
medRxiv. 2023 Nov 29:2023.11.29.23299130. doi: 10.1101/2023.11.29.23299130.
5
Quantifying variation in home spirometry in people with cystic fibrosis during baseline health, and associations with clinical outcomes.定量分析囊性纤维化患者在基线健康时的家庭肺功能测定中的变异情况,及其与临床结局的关系。
J Cyst Fibros. 2024 Mar;23(2):321-328. doi: 10.1016/j.jcf.2023.05.011. Epub 2023 May 26.
囊性纤维化气道微生物组在临床稳定期的测量。
Ann Am Thorac Soc. 2019 Dec;16(12):1534-1542. doi: 10.1513/AnnalsATS.201903-270OC.
4
DADA2: High-resolution sample inference from Illumina amplicon data.DADA2:从Illumina扩增子数据进行高分辨率样本推断。
Nat Methods. 2016 Jul;13(7):581-3. doi: 10.1038/nmeth.3869. Epub 2016 May 23.
5
Cystic fibrosis lung microbiome: opportunities to reconsider management of airway infection.囊性纤维化肺部微生物群:重新审视气道感染管理的机遇
Pediatr Pulmonol. 2015 Oct;50 Suppl 40:S31-8. doi: 10.1002/ppul.23243.
6
Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease.粪便微生物群移植可消除复发性疾病小鼠模型中的艰难梭菌。
Infect Immun. 2015 Oct;83(10):3838-46. doi: 10.1128/IAI.00459-15. Epub 2015 Jul 13.
7
Effect of sample storage conditions on culture-independent bacterial community measures in cystic fibrosis sputum specimens.样本储存条件对囊性纤维化痰液标本中不依赖培养的细菌群落检测结果的影响。
J Clin Microbiol. 2011 Oct;49(10):3717-8. doi: 10.1128/JCM.01189-11. Epub 2011 Aug 24.
8
QIIME allows analysis of high-throughput community sequencing data.QIIME可用于分析高通量群落测序数据。
Nat Methods. 2010 May;7(5):335-6. doi: 10.1038/nmeth.f.303. Epub 2010 Apr 11.
9
Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities.定量和定性的β多样性测度会产生关于构建微生物群落的因素的不同见解。
Appl Environ Microbiol. 2007 Mar;73(5):1576-85. doi: 10.1128/AEM.01996-06. Epub 2007 Jan 12.